Step 1 of 2
Explore current melanoma immunotherapy strategies for resectable and metastatic disease, including neoadjuvant and adjuvant treatment, pathologic response assessment, individualized neoantigen therapy, and treatment sequencing. Review recent clinical trial evidence, immune-related adverse event management, and multidisciplinary workflows to support personalized care.